Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry

Figure 2

Co-morbidity burden and health related quality of life (EQ-5D). Legend: co-morbidities considered were dyslipidemia, hypertension, malignancy, coronary artery disease, stroke/transitory ischemic attack (TIA), peripheral artery disease (PAD), heart failure, neuropathy, retinopathy, dialysis, clinically relevant depression.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840